Home › Metabolic Syndrome › NCT07927283
Fulvic Acid Supplementation and Metabolic Syndrome
Evaluation of Fulvic Acid Supplementation for the Attenuation of Symptoms Associated With Metabolic Syndrome
Who can join
Ages 18 to 65 · All sexes
Full eligibility criteria
Inclusion Criteria: * metabolic syndrome or prediabetes Exclusion Criteria: * pregnant or nursing * multiple medications to treat obesity, heart disease, thyroid conditions, cancer * smokers * competing athletes * vegetarians
About the study
Fulvic acid is a naturally occurring compound derived from the decomposition of organic matter in soil over long periods. Fulvic acid complexes, such as MLG-50 (MLG-50® Mineral Logic, Kalamazoo, Michigan), offer a highly concentrated, water-soluble form of fulvic acid that contains over 70 trace minerals and elements. Our preclinical studies have found that a soil derived organic mineral complex rich in fulvic acid prevented the high fat diet induced hyperglycemia, endothelial dysfunction, liver injury, endotoxemia, and gut dysbiosis induced by high-fat feeding in rats. We propose to examine the efficacy of fulvic acid (both 50 mg and 100 mg daily for 12 weeks) in the mitigation of symptoms related to metabolic syndrome.
What is being tested
- fulvic acid (dietary supplement)
- fulvic acid (dietary supplement)
- Placebo (other)
Sponsor: Arizona State University · Participants: 60 · Started: Nov 6, 2026
Contact the study team
- Carol Johnston, PhD · Phone: 6024963463
- Karen Sweazea, PhD · Phone: 4809656025
Official record on ClinicalTrials.gov — NCT07927283
Locations in the U.S.
| Arizona | PBC 850 N 5th Street, Phoenix |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.